secwatch.observer — SEC 8-K summary
======================================

Issuer:     DAVITA INC. (DVA)
CIK:        0000927066
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0000927066-24-000089
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DaVita Q1 2024 net income $240M, EPS $2.65; revenue $3.07B
----------------------------------------------------------

- Revenue $3.071B; operating income $484M; adjusted operating income $463M.
- Diluted EPS $2.65 (up from $1.25 in Q1 2023); adjusted diluted EPS $2.38 (vs $1.58).
- Operating cash flow $(135)M; free cash flow $(327)M due to working capital timing.
- Repurchased 2.1M shares at average price $112.76 per share.
- CEO cites continued operational discipline and investment in clinical excellence.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/927066/000092706624000089/0000927066-24-000089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/927066/000092706624000089/dva-20240502.htm
  HTML page:      https://secwatch.observer/filing/0000927066-24-000089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer